19
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Hepatitis C and the Leptin System: Bound Leptin Levels Are Elevated in Patients with Hepatitis C and Decrease During Antiviral Therapy

Pages 426-431 | Published online: 08 Jul 2009

References

  • WHO. Hepatitis: global prevalence. Wkly Epidemiol Rec 1997; 72:341–4.
  • Tillmann HL, Manns MP. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci 1996;41:27S–40S.
  • Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347–56.
  • Lindsay KL. Therapy of hepatitis C: overview. Hepatology 1997;26:71S–7S.
  • Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosy-1,2,4-triazole-3-carb oxamide. Science 1972; 177:705–6.
  • Bodenheimer HC, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seef LB. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 1997;26: 473–7.
  • Dusheiko G, Main J, Thomas H, et al. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol 1996;25:591–8.
  • Wedemeyer H, Caselmann WH, Manns MP. Combination therapy of chronic hepatitis C. J Hepatol 1998;29:1010–4.
  • McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998;115:947–53.
  • Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:543–6.
  • Houseknecht KL, Mantzoros C, Kuliawat R, Hadro E, Flier J, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 1996; 45:1638–43.
  • Ockenga J, Widjaja A, Holtmannspötter M, Schmidt RE, Brabant G. Bound leptin is regulated by tumor necrosis factoralpha in HIV-infected patients: a potential mediator of wasting? AIDS 1998;12:2233–5.
  • De Vos R, Guisez Y, Van der Heyden J, et al. Ligandindependent dimerization of the extracellular domain of the leptin receptor and determination of the stoichometry of leptin binding. J Biol Chem 1997;272:18304–10.
  • Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632–5.
  • Sinha MK, Opentatova I, Ohanessian J, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98: 1277–82.
  • Gainsford T, Willson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci 1996;93:14564–8.
  • Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57–65.
  • Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152–7.
  • Zumbach MS, Boehme MWJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997;82:4080–2.
  • Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998;244:178–82.
  • McClain CJ, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170–82.
  • Martin J, Navas S, Quiroga JA, Pardo M, Carreno V. Effects of ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine 1998;10:635–44.
  • Pansky A, Hildebrand P, Heim MH, Eberhard M, Kissel T, Beglinger C. Growth effects of alpha interferon but not of bombesin or angiotensin II are mediated by activation of STAT proteins. Eur J Clin Invest 1998;28:398–406.
  • Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signalling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 1996;93:8374–8.
  • Wedemeyer H, Hannah F, Trautwein C, et al. Liver steatosis and response to interferon alpha in patients with chronic hepatitis C. J Viral Hepatology. In press.
  • Aderka J, Sorkine P, Abu-Abid S, et al. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. J Clin Invest 1998; 101:650–9.
  • Horn R, Geldszus R, Potter E, von zur Muhlen A, Brabant G. Radioimmunoassay for the detection of leptin in human serum. Exp Clin Endocrinol Diabetes 1996;104:454–8.
  • Lewandowski K, Horn R, O’Callaghan CJ, et al. Free leptin, bound leptin and soluble leptin receptor in normal and diabetic pregnancy. J Clin Endocrinol Metab 1999;84:300–6.
  • Süttmann U, Selberg O, Gallati H, Ockenga J, Deicher H, Müller MJ. Tumor necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients. Clin Sci 1994;86:461–7.
  • Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing Histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;5:431–5.
  • Widjaja A, Stratton IM, Horn R, Holman RR, Turner RC, Brabant G. UKPDS 20: Plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 1997;82:654–7.
  • Geldszus R, Mayr B, Horn R, Geisthovel F, von zur Muhlen A, Brabant G. Serum leptin and weight reduction in female obesity. Eur J Endocrinol 1996;135:659–62.
  • Brabant G, Horn R, von zur Mühlen A, et al. Free and protein bound leptin are distinct and independently controlled factors in energy regulation. Diabetologia 2000;43:438–42.
  • Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology 1999;29:1018–24.
  • Ockenga J, Bischoff SC, Tillmann HJ, et al. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000;119:1656–62.
  • Bonara E, Orioli S, Coscelli C, Buzelli G, Gentilini P, Butturini U. Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver disease. Acta Diabetol Lat 1984;21:241–50.
  • Orbach O, Schussler GC. Increased serum cortisol binding in chronic active hepatitis. Am J Med 1989;86:39–42.
  • Mihm S, Fayyazi A, Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology 1997;26:451–8.
  • Widjaja A, Schürmeyer TH, von zur Mühlen A, Brabant G. Determinants of serum leptin levels in Cushing’ s syndrome. J Clin Endocrinol Metab 1998;83:600–3.
  • Morley JE, Kumar VB, Mattammal M, Villareal DT. Measurement of nitric oxide synthetase and its mRNA in genetically obese (ob/ob) mice. Life Sci 1995;57:1327–31.
  • Czaja AJ, Carpenter HA, Santrach PJ, et al. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998;29:198–206.
  • Giannini E, Botta F, Cataldi A, et al. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 1999; 46:2422–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.